BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 9693224)

  • 1. Combination therapy with neuroprotectants and thrombolytics in acute ischaemic stroke.
    Steiner T; Hacke W
    Eur Neurol; 1998 Jul; 40(1):1-8. PubMed ID: 9693224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination therapy for ischemic stroke: potential of neuroprotectants plus thrombolytics.
    Chen SD; Lee JM; Yang DI; Nassief A; Hsu CY
    Am J Cardiovasc Drugs; 2002; 2(5):303-13. PubMed ID: 14727960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with melagatran alone or in combination with thrombolytic therapy reduced ischemic brain injury.
    Wang CX; Ding X; Shuaib A
    Exp Neurol; 2008 Sep; 213(1):171-5. PubMed ID: 18598697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Thrombolytics and neuroprotective agents in the treatment of the patient with an acute cerebrovascular ischemic accident].
    Yepes MS
    Rev Neurol; 2001 Feb 1-15; 32(3):259-66. PubMed ID: 11310282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombolysis and neuroprotection in cerebral ischemia.
    Gutiérrez M; Díez Tejedor E; Alonso de Leciñana M; Fuentes B; Carceller F; Roda JM
    Cerebrovasc Dis; 2006; 21 Suppl 2():118-26. PubMed ID: 16651822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The only evidence based neuroprotective therapy for acute ischemic stroke: thrombolysis.
    Köhrmann M; Schellinger PD; Schwab S
    Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):563-71. PubMed ID: 21619867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotection in cerebrovascular disease.
    Jain KK
    Expert Opin Investig Drugs; 2000 Apr; 9(4):695-711. PubMed ID: 11060703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ischaemic tolerance: a window to endogenous neuroprotection?
    Schaller B; Graf R; Jacobs AH
    Lancet; 2003 Sep; 362(9389):1007-8. PubMed ID: 14522526
    [No Abstract]   [Full Text] [Related]  

  • 9. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotection as initial therapy in acute stroke. Third Report of an Ad Hoc Consensus Group Meeting. The European Ad Hoc Consensus Group.
    Cerebrovasc Dis; 1998; 8(1):59-72. PubMed ID: 9645985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective, randomized, placebo-controlled, double-blind trial about safety and efficacy of combined treatment with alteplase (rt-PA) and Cerebrolysin in acute ischaemic hemispheric stroke.
    Lang W; Stadler CH; Poljakovic Z; Fleet D;
    Int J Stroke; 2013 Feb; 8(2):95-104. PubMed ID: 23009193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotection in acute ischaemic stroke. II: Clinical potential.
    Davis M; Barer D
    Vasc Med; 1999; 4(3):149-63. PubMed ID: 10512595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic advances in acute ischaemic stroke.
    Bhalla A; Rudd AG
    Int J Clin Pract; 1999 Jun; 53(4):295-300. PubMed ID: 10563075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recanalization and reperfusion therapies for acute ischemic stroke.
    Molina CA; Alvarez-Sabín J
    Cerebrovasc Dis; 2009; 27 Suppl 1():162-7. PubMed ID: 19342847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pilot dose-escalation study of caffeine plus ethanol (caffeinol) in acute ischemic stroke.
    Piriyawat P; Labiche LA; Burgin WS; Aronowski JA; Grotta JC
    Stroke; 2003 May; 34(5):1242-5. PubMed ID: 12690224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic potential of herbal drugs in cerebral ischemia.
    Gupta YK; Briyal S; Gulati A
    Indian J Physiol Pharmacol; 2010; 54(2):99-122. PubMed ID: 21090528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Thrombolysis and neuroprotection in cerebral ischemia. Future perspectives].
    Castillo J; Martínez-Vila E; Naveiro J; Vázquez C
    Rev Clin Esp; 1996 Nov; 196 Suppl 3():29-36. PubMed ID: 11000895
    [No Abstract]   [Full Text] [Related]  

  • 18. Limiting neurological damage after stroke: a review of pharmacological treatment options.
    Read SJ; Hirano T; Davis SM; Donnan GA
    Drugs Aging; 1999 Jan; 14(1):11-39. PubMed ID: 10069406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical management of acute cerebral ischemia.
    Biller J
    Neurol Clin; 1992 Feb; 10(1):63-85. PubMed ID: 1557010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ischaemic stroke: acute-phase drug therapy. Mostly aspirin and heparin.
    Prescrire Int; 2005 Aug; 14(78):146-52. PubMed ID: 16106599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.